Hakai-mediated down-regulation of E-cadherin is involved in oncogenic and/or tumor-suppressive signaling pathways such as RACK1 and Slit-Robo signaling during tumor progression [31, 33, 34]. The gene discussed is CDH1; the disease is neoplasm.